2BB score and signals
Kalaris Therapeutics, Inc.’s current 2BB score is 27 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 20 | Low |
| Momentum | 53 | Stable |
| Financial strength | 35 | Weak |
| Quality | 40 | Normal |
| Risk | 66 | High |
Company facts
| Headquarters | Berkeley Heights, New Jersey, United States |
| Founded | 2019 |
| Employees | 20 |
| 52-week range | $2.11 – $11.88 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-15 | — | -0.5423 | — | $0.00 |
| 2026-11-10 | — | -0.5188 | — | $0.00 |
| 2026-08-19 | — | -0.5049 | — | $0.00 |
| 2026-05-12 | -0.46 | -0.5336 | $0.00 | $0.00 |
Related companies
